📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ADAM17-Mediated Reduction in CD14++CD16+ Monocytes ex vivo and Reduction in Intermediate Monocytes With Immune Paresis in Acute Pancreatitis and Acute Alcoholic Hepatitis. (2019)

First Author: Waller K

Attributed to: Stat2 is a therapeutic target in liver inflammation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.01902

PubMed Identifier: 31507587

Publication URI: http://europepmc.org/abstract/MED/31507587

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in immunology

ISSN: 1664-3224